H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 77 Citations 19,788 389 World Ranking 735 National Ranking 4
Medicine D-index 96 Citations 33,065 711 World Ranking 4535 National Ranking 20

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Inflammation

Pål Aukrust spends much of his time researching Internal medicine, Immunology, Endocrinology, Heart failure and Inflammation. The study incorporates disciplines such as Gastroenterology and Cardiology in addition to Internal medicine. His study in Cytokine, Tumor necrosis factor alpha, Interleukin, Chemokine and Monocyte are all subfields of Immunology.

His Endocrinology research is multidisciplinary, relying on both Receptor, Nonalcoholic fatty liver disease, T cell and Receptor antagonist. The various areas that Pål Aukrust examines in his Heart failure study include Heart disease, Rosuvastatin and Hazard ratio. His study in Inflammation is interdisciplinary in nature, drawing from both Lesion, Pathogenesis, Platelet activation, Platelet and Vascular disease.

His most cited work include:

  • Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes (496 citations)
  • Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (425 citations)
  • Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 (418 citations)

What are the main themes of his work throughout his whole career to date?

Pål Aukrust mainly investigates Internal medicine, Immunology, Inflammation, Endocrinology and Cardiology. His research links Gastroenterology with Internal medicine. Much of his study explores Immunology relationship to Peripheral blood mononuclear cell.

His studies in Inflammation integrate themes in fields like Platelet activation, Receptor and Pathogenesis, Pathology. His Endocrinology research is multidisciplinary, incorporating perspectives in Inflammasome and Osteoprotegerin. His Cardiology study combines topics from a wide range of disciplines, such as Surgery and Hazard ratio.

He most often published in these fields:

  • Internal medicine (77.79%)
  • Immunology (40.14%)
  • Inflammation (35.51%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (77.79%)
  • Inflammation (35.51%)
  • Immunology (40.14%)

In recent papers he was focusing on the following fields of study:

Pål Aukrust mostly deals with Internal medicine, Inflammation, Immunology, Endocrinology and Cardiology. His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology. His Inflammation study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Lipoprotein, Transplantation and Monocyte.

His studies deal with areas such as Peripheral blood mononuclear cell and Disease as well as Immunology. Insulin resistance is closely connected to Inflammasome in his research, which is encompassed under the umbrella topic of Endocrinology. As part of one scientific family, he deals mainly with the area of Cardiology, narrowing it down to issues related to the Randomized controlled trial, and often Rosuvastatin.

Between 2017 and 2021, his most popular works were:

  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. (408 citations)
  • Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint) (121 citations)
  • Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. (50 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Immune system

Internal medicine, Immunology, Inflammation, Myocardial infarction and Cardiology are his primary areas of study. Pål Aukrust interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine. As a part of the same scientific study, he usually deals with the Immunology, concentrating on Odds ratio and frequently concerns with Respiratory system, Case-control study, Complement system, Lectin pathway and Coronavirus.

The Inflammation study combines topics in areas such as COPD, Lung cancer, FOXP3 and Innate immune system. His biological study spans a wide range of topics, including Coronary artery disease and Tocilizumab, Disease. The concepts of his Cardiology study are interwoven with issues in Endurance training, Physical exercise and C-reactive protein.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes

Pål Aukrust;Fredrik Müller;Thor Ueland;Trude Berget.
Circulation (1999)

758 Citations

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Pål Aukrust;Thor Ueland;Egil Lien;Klaus Bendtzen.
American Journal of Cardiology (1999)

680 Citations

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

Hongchao Pan;Richard Peto;Ana-Maria Henao-Restrepo.
The New England Journal of Medicine (2020)

614 Citations

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

John Willy Haukeland;Jan Kristian Damås;Zbigniew Konopski;Else Marit Løberg.
Journal of Hepatology (2006)

540 Citations

Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure

Pål Aukrust;Thor Ueland;Fredrik Müller;Arne K. Andreassen.
Circulation (1998)

487 Citations

Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters

Pål Aukrust;Nina-Beate Liabakk;FredrikMü ller;Egil Lien.
The Journal of Infectious Diseases (1994)

432 Citations

Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure

Lars Gullestad;Halfdan Aass;Jan G. Fjeld;Lisbeth Wikeby.
Circulation (2001)

432 Citations

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury

Øystein Sandanger;Trine Ranheim;Leif Erik Vinge;Leif Erik Vinge;Marte Bliksøen.
Cardiovascular Research (2013)

352 Citations

Systemic inflammation in heart failure--the whys and wherefores.

Arne Yndestad;Jan Kristian Damås;Erik Oie;Thor Ueland.
Heart Failure Reviews (2006)

338 Citations

Inflammatory cytokines in heart failure: mediators and markers.

Lars Gullestad;Thor Ueland;Leif Erik Vinge;Alexandra Finsen.
The Cardiology (2012)

316 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pål Aukrust

Thor Ueland

Thor Ueland

Oslo University Hospital

Publications: 86

Rolf K. Berge

Rolf K. Berge

University of Bergen

Publications: 80

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 75

Lars Gullestad

Lars Gullestad

Oslo University Hospital

Publications: 63

Christian Weber

Christian Weber

Ludwig Maximilian University of Munich

Publications: 52

Kjetil Taskén

Kjetil Taskén

Oslo University Hospital

Publications: 50

Srdjan Djurovic

Srdjan Djurovic

Oslo University Hospital

Publications: 50

Stig S. Frøland

Stig S. Frøland

University of Oslo

Publications: 46

Alan S. Maisel

Alan S. Maisel

University of California, San Diego

Publications: 38

Rudolf A. de Boer

Rudolf A. de Boer

University Medical Center Groningen

Publications: 37

James L. Januzzi

James L. Januzzi

Harvard University

Publications: 35

Antonio Abbate

Antonio Abbate

University of Virginia

Publications: 34

W.H. Wilson Tang

W.H. Wilson Tang

Cleveland Clinic

Publications: 34

Tom Eirik Mollnes

Tom Eirik Mollnes

Oslo University Hospital

Publications: 34

Jordan S. Orange

Jordan S. Orange

Columbia University

Publications: 33

Asghar Aghamohammadi

Asghar Aghamohammadi

Tehran University of Medical Sciences

Publications: 32

Something went wrong. Please try again later.